ArticleAntioxidants (Basel, Switzerland)2022

Targeting the NRF2/HO-1 Antioxidant Pathway in FLT3-ITD-Positive AML Enhances Therapy Efficacy.

Sankaranarayan Kannan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.